Combination antiretroviral (ARV) treatment has significantly increased survival in people diagnosed with AIDS-related illnesses of the brain,...

An international study comparing Norvir (ritonavir)-boosted Prezista (darunavir) to Kaletra (lopinavir/ritonavir) in people starting treatment...

The higher a person’s CD4 count upon starting HIV treatment, the higher their CD4 count will be 60 months later, say British researchers at th...

An experimental lower-strength tablet version of Kaletra (lopinavir plus ritonavir) is expected to work well in HIV-positive children

Slow but steady progress is being made on several HIV prevention fronts, say researchers in a special symposium on HIV prevention at the 11th...

A decade after beginning triple-drug therapy with very low CD4 counts, a majority of patients in Belgian PICASSO cohort study remain alive

Crestor is superior to Pravachol in HIV-positive people on antiretroviral therapy who experience LDL cholesterol and triglyceride elevations

Dr. Jose Ramos talks with Peter Staley about the unique challenges facing HIV-positive children and their health care providers.

Dr. José Gatell talks with David Evans about the latest treatment news on Selzentry, rilpivirine (TMC278) and the continued interest...

The experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine is comparable to Sustiva in terms of reducing HIV levels a...